- Neoadjuvant Therapy Should Be the Standard of Care for Every Node Positive Breast Cancer Patient
-
Hamdy O
- KMID: 2441860
- J Breast Cancer.
- 2019 Mar;22(1):149-152.
- doi: 10.4048/jbc.2019.22.e3
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Whole Exome Sequencing in the Accurate Diagnosis of Bilateral Breast Cancer: a Case Study
-
Li X, Yang M, Zhang Q, Fan Y, Zhu T, Chen F, Wang K
- KMID: 2441858
- J Breast Cancer.
- 2019 Mar;22(1):131-140.
- doi: 10.4048/jbc.2019.22.e10
When faced with a case of bilateral breast cancer (BBC), understanding how to differentiate bilateral primary breast cancer from contralateral metastatic breast cancer is essential for treatment, but clear identification... -
- CITED
-
- Close
- SHARE
-
- Close
- Erratum: Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry
-
Kang SY, Kim YS, Kim Z, Kim HY, Lee SK, Jung KW, Youn HJ, Korean Breast Cancer Society
- KMID: 2441861
- J Breast Cancer.
- 2019 Mar;22(1):153-153.
- doi: 10.4048/jbc.2019.22.e12
This article was initially published on the Journal of Breast Cancer with a misspelled legend display in Figure 3. The postmenopause and premenopause should be changed with each other. -
- CITED
-
- Close
- SHARE
-
- Close
- Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin
-
Abdel Azim H, Kassem L, Shohdy KS, Eshaak B, Anis SE, Kamal NS
- KMID: 2441859
- J Breast Cancer.
- 2019 Mar;22(1):141-148.
- doi: 10.4048/jbc.2019.22.e2
The luteinizing hormone-releasing hormone/androgen receptor (LHRH/AR) pathway is a promising treatment target in a subgroup of female patients with triple-negative breast cancer (TNBC). However, very little is known about the... -
- CITED
-
- Close
- SHARE
-
- Close
- Circulating Plasmacytoid and Myeloid Dendritic Cells in Breast Cancer Patients: A Pilot Study
-
Paek SH, Kim HG, Lee JW, Woo J, Kwon H, Kim JB, Lim W, Kim JR, Moon BI, Paik NS
- KMID: 2441849
- J Breast Cancer.
- 2019 Mar;22(1):29-37.
- doi: 10.4048/jbc.2019.22.e15
PURPOSE: Dendritic cells (DC) are a class of bone marrow-derived cells found in the blood, epithelia, and lymphoid tissues, and are the most efficient antigen presenting cells. The number and... -
- CITED
-
- Close
- SHARE
-
- Close
- Prescription Refill Gap of Endocrine Treatment from Electronic Medical Records as a Prognostic Factor in Breast Cancer Patients
-
Lee Y, Park YR, Lee JS, Lee SB, Chung IY, Son BH, Ahn SH, Lee JW
- KMID: 2441854
- J Breast Cancer.
- 2019 Mar;22(1):86-95.
- doi: 10.4048/jbc.2019.22.e14
PURPOSE: Discontinuation of hormone therapy is known to lead to a poorer prognosis in breast cancer patients. We aimed to investigate the prescription gap as a prompt index of medication... -
- CITED
-
- Close
- SHARE
-
- Close
- BRCA1 and Breast Cancer: a Review of the Underlying Mechanisms Resulting in the Tissue-Specific Tumorigenesis in Mutation Carriers
-
Semmler L, Reiter-Brennan C, Klein A
- KMID: 2441847
- J Breast Cancer.
- 2019 Mar;22(1):1-14.
- doi: 10.4048/jbc.2019.22.e6
Since the first cloning of BRCA1 in 1994, many of its cellular interactions have been elucidated. However, its highly specific role in tumorigenesis in the breast tissue—carriers of BRCA1 mutations... -
- CITED
-
- Close
- SHARE
-
- Close
- Immediate Breast Reconstruction Does Not Have a Clinically Significant Impact on Adjuvant Treatment Delay and Subsequent Survival Outcomes
-
Baek SH, Bae SJ, Yoon CI, Park SE, Cha CH, Ahn SG, Kim YS, Roh TS, Jeong J
- KMID: 2441856
- J Breast Cancer.
- 2019 Mar;22(1):109-119.
- doi: 10.4048/jbc.2019.22.e7
PURPOSE: The use of immediate breast reconstruction (IBR) has been debated because it may be a causative factor in adjuvant treatment delay and may subsequently increase the probability of recurrence.... -
- CITED
-
- Close
- SHARE
-
- Close
- Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death
-
Fu J, Zhong C, Wu L, Li D, Xu T, Jiang T, Yang J, Du J
- KMID: 2441855
- J Breast Cancer.
- 2019 Mar;22(1):96-108.
- doi: 10.4048/jbc.2019.22.e13
PURPOSE: Although it is widely accepted that hormone receptor (HR) status is associated with later post-diagnostic periods, a debate exists as to whether the association is independent of age. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Determining Whether High Nodal Burden in Early Breast Cancer Patients Can Be Predicted Preoperatively to Avoid Sentinel Lymph Node Biopsy
-
Lim GH, Teo SY, Allen JC, Chinthala , Leong LC
- KMID: 2441852
- J Breast Cancer.
- 2019 Mar;22(1):67-76.
- doi: 10.4048/jbc.2019.22.e8
PURPOSE: The Z0011 trial showed that axillary lymph node dissection (ALND) can be safely avoided in breast cancer patients with low nodal burden (LNB). ALND can be performed in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Pokemon Inhibits Transforming Growth Factor β-Smad4-Related Cell Proliferation Arrest in Breast Cancer through Specificity Protein 1
-
Chen L, Zhong J, Liu JH, Liao DF, Shen YY, Zhong XL, Xiao X, Ding WJ, Peng XD, Xiong W, Zu XY
- KMID: 2441848
- J Breast Cancer.
- 2019 Mar;22(1):15-28.
- doi: 10.4048/jbc.2019.22.e11
PURPOSE: Pokemon, also known as ZBTB7A, belongs to the POZ and Krüppel (POK) family of transcription repressors and is implicated in tumor progression as a key proto-oncogene. This present study... -
- CITED
-
- Close
- SHARE
-
- Close
- CD9 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Lobular Carcinoma
-
Baek J, Jang N, Choi JE, Kim JR, Bae YK
- KMID: 2441853
- J Breast Cancer.
- 2019 Mar;22(1):77-85.
- doi: 10.4048/jbc.2019.22.e9
PURPOSE: We investigated the prognostic significance of CD9 expression in tumor cells of patients with invasive lobular carcinoma (ILC). METHODS: CD9 expression was evaluated by immunohistochemistry in 113 ILC tissue samples.... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
-
Jeong H, Hwang I, Kang SH, Shin HC, Kwon SY
- KMID: 2441850
- J Breast Cancer.
- 2019 Mar;22(1):38-51.
- doi: 10.4048/jbc.2019.22.e5
PURPOSE: Tumor-associated macrophages (TAMs) are activated macrophages associated with tumor progression in various cancers. TAMs can polarize M1 or M2 type. M1 has a pro-inflammatory function and kills pathogens. Conversely,... -
- CITED
-
- Close
- SHARE
-
- Close
- Screening of Recurrence Related MicroRNA in Ductal Carcinoma In Situ and Functional Study of MicroRNA-654-5p
-
Li S, Pu T, Xiao L, Gao H, Li L, Ye F, Liu Y, Bu H
- KMID: 2441851
- J Breast Cancer.
- 2019 Mar;22(1):52-66.
- doi: 10.4048/jbc.2019.22.e4
PURPOSE: Ductal carcinoma in situ (DCIS) contributes to 20%–30% of newly diagnosed cases of breast cancer in China. Although the breast cancer-specific mortality of DCIS is extremely low, a small... -
- CITED
-
- Close
- SHARE
-
- Close
- Central Nervous System Failure in Korean Breast Cancer Patients with HER2-Enriched Subtype: Korean Radiation Oncology Group 16-15 Multicenter Retrospective Study
-
Kim K, Shin KH, Kim JH, Choi DH, Park W, Kim YB, Kim HJ, Kim JH, Park H, Lee SY, Kim J, Oh DH, Kim IA
- KMID: 2441857
- J Breast Cancer.
- 2019 Mar;22(1):120-130.
- doi: 10.4048/jbc.2019.22.e1
PURPOSE: The purpose of this study was to evaluate the risk of central nervous system (CNS) failure in Korean patients with human epidermal growth factor receptor 2 (HER2)-enriched breast cancer... -
- CITED
-
- Close
- SHARE
-
- Close
